4.5 Article

Epidemiology of childhood-onset type 1 diabetes in Azerbaijan: Incidence, clinical features, biochemistry, and HLA-DRB1 status

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 144, Issue -, Pages 252-259

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2018.09.009

Keywords

Childhood diabetes; Azerbaijan; Incidence; Autoimmunity; HLA

Funding

  1. Leona M and Harry B Helmsley Charitable Trust

Ask authors/readers for more resources

Aims: Determine the incidence and typology of diabetes in children in Azerbaijan. Methods: Clinical features, C-peptide, autoantibodies (glutamic acid decarboxylase 65 (GAD65) and islet antigen 2 (IA-2)), and HLA-DRB1 status were studied in 106 subjects < 18 years of age who were recently diagnosed. 104 cases were consecutive. Incidence was determined for Baku and Absheron regions, where ascertainment is estimated to be essentially 100%. Results: 104 of the 106 (98%) were diagnosed with type 1 diabetes, one with type 2 diabetes and one with atypical diabetes. Type 1 diabetes incidence in Baku City and Absheron was 7.05 per 100,000 population < 15 years per year. Peak age of onset was 10 years. There was a slight male preponderance (male: female 1.17: 1), and no temporal association with seasons. Almost all type 1 diabetes subjects presented with classic symptoms including a high incidence (58%) of diabetic ketoacidosis. 86% presented with low C-peptide values (< 0.13 nmol/L, < 0.40 ng/mL) and 74% were positive for at least one type 1 diabetes-related autoantibody. Conclusions: Azerbaijan has a moderate type 1 diabetes incidence and clinical, biochemical and genetic features similar to that in European populations. (C) 2018 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available